Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction

NCT02652091 · clinicaltrials.gov ↗

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Interferon beta-1b (Betaseron, BAY86-5046)
DEVICE: BETACONNECT device

Sponsor

Bayer